Ningning Mi
Impact in
-
- Gout, Hyperuricemia, Uric Acid
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Surgery 9
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
-
- Gout, Hyperuricemia, Uric Acid 3
- Co-authors
- Jinqiu Yuan (16 shared papers)Wenbo Meng (19 shared papers)Yanyan Lin (16 shared papers)Ping Yue (15 shared papers)Long Gao (11 shared papers)Qiangsheng He (17 shared papers)Ya‐Wen Lu (6 shared papers)Xianzhuo Zhang (5 shared papers)
- Journals
- Frontiers in Pharmacology (5 papers)Frontiers in Oncology (3 papers)BMC Medicine (3 papers)BMC Cancer (2 papers)EClinicalMedicine (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ningning Mi
38 papers receiving 244 citations
Peers
Comparison fields: 5 of 62
- Nephrology 33
- Hepatology 17
- Oncology 30
- Health Informatics 3
- Gastroenterology 7
Countries citing papers authored by Ningning Mi
This map shows the geographic impact of Ningning Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningning Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningning Mi more than expected).
Fields of papers citing papers by Ningning Mi
This network shows the impact of papers produced by Ningning Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningning Mi. The network helps show where Ningning Mi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ningning Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 32 | |
| 2 | 2020 | 26 | |
| 3 | 2021 | 20 | |
| 4 | 2024 | 13 | |
| 5 | 2020 | 10 | |
| 6 | 2024 | 10 | |
| 7 | 2020 | 9 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 9 | |
| 10 | 2024 | 9 | |
| 11 | 2024 | 8 | |
| 12 | 2023 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 6 | |
| 17 | 2024 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2024 | 5 |
About Ningning Mi
Ningning Mi is a scholar working on Surgery, Nephrology, Genetics, Gastroenterology and Hepatology, having authored 42 papers that have together received 248 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Nutritional Studies and Diet (4 papers), Gallbladder and Bile Duct Disorders (4 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Inflammatory Bowel Disease (3 papers), Dementia and Cognitive Impairment Research (2 papers), Folate and B Vitamins Research (2 papers) and Gastrointestinal motility and disorders (2 papers). The work is most often cited by research in Nephrology (33 citations), Hepatology (17 citations), Oncology (30 citations), Health Informatics (3 citations) and Gastroenterology (7 citations). Ningning Mi has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jinqiu Yuan, Wenbo Meng, Yanyan Lin, Ping Yue, Long Gao, Qiangsheng He, Ya‐Wen Lu, Xianzhuo Zhang, Chao Zhang and Bin Xia. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Oncology, BMC Medicine, BMC Cancer and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.